Latest News

What makes some states more popular to specific financial services providers?

What makes some states more popular to specific financial services providers?

The United States of America stands out as the leading economic powerhouse globally; a reputation it has held for several centuries now. The assumptions most people often have; especially those who have lived in the US, is that the whole of the US is equally developed with citizens having equal access to quality service delivery […]
Kamada Ltd. (KMDA) Downgraded by Zacks Investment Research to Strong Sell

Kamada Ltd. (KMDA) Downgraded by Zacks Investment Research to Strong Sell

Kamada Ltd. (NASDAQ:KMDA) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report issued on Thursday. According to Zacks, “Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other […]
Hibbett Sports, Inc. (HIBB) Lifted to “Hold” at Forward View

Hibbett Sports, Inc. (HIBB) Lifted to “Hold” at Forward View

Hibbett Sports, Inc. (NASDAQ:HIBB) was upgraded by investment analysts at Forward View to a “hold” rating in a note issued to investors on Saturday. The brokerage currently has a $18.00 price target on the stock. Forward View’s target price points to a potential upside of 5.26% from the stock’s previous close. Several other analysts also […]
Marshalls plc (MSLH) Raised to “Buy” at Berenberg Bank

Marshalls plc (MSLH) Raised to “Buy” at Berenberg Bank

Marshalls plc (LON:MSLH) was upgraded by equities research analysts at Berenberg Bank to a “buy” rating in a research report issued to clients and investors on Thursday. Other equities research analysts have also issued research reports about the company. Peel Hunt restated a “buy” rating and set a GBX 450 ($5.92) price objective on shares […]
Rank Group PLC (RNK) Rating Increased to Buy at Peel Hunt

Rank Group PLC (RNK) Rating Increased to Buy at Peel Hunt

Rank Group PLC (LON:RNK) was upgraded by equities researchers at Peel Hunt to a “buy” rating in a report issued on Thursday. The firm presently has a GBX 265 ($3.49) price target on the stock. Peel Hunt’s target price would indicate a potential upside of 13.34% from the stock’s current price. Other research analysts also […]
Kepler Capital Markets Upgrades Centrica PLC (CNA) to “Buy”

Kepler Capital Markets Upgrades Centrica PLC (CNA) to “Buy”

Centrica PLC (LON:CNA) was upgraded by equities research analysts at Kepler Capital Markets to a “buy” rating in a report issued on Thursday, Marketbeat.com reports. The firm presently has a GBX 190 ($2.50) price target on the integrated energy company’s stock. Kepler Capital Markets’ price objective suggests a potential upside of 16.42% from the company’s […]
FirstGroup plc (FGP) Upgraded to Hold at Deutsche Bank AG

FirstGroup plc (FGP) Upgraded to Hold at Deutsche Bank AG

FirstGroup plc (LON:FGP) was upgraded by investment analysts at Deutsche Bank AG to a “hold” rating in a research report issued on Thursday, Marketbeat reports. The brokerage currently has a GBX 100 ($1.32) target price on the transport operator’s stock, up from their previous target price of GBX 94 ($1.24). Deutsche Bank AG’s price objective […]
AVEVA Group plc (AVV) Upgraded to “Overweight” at J P Morgan Chase & Co

AVEVA Group plc (AVV) Upgraded to “Overweight” at J P Morgan Chase & Co

AVEVA Group plc (LON:AVV) was upgraded by research analysts at J P Morgan Chase & Co to an “overweight” rating in a note issued to investors on Thursday. The firm presently has a GBX 3,200 ($42.09) price target on the stock, up from their previous price target of GBX 2,800 ($36.83). J P Morgan Chase […]
Close Brothers Group plc (CBG) Rating Increased to Buy at Peel Hunt

Close Brothers Group plc (CBG) Rating Increased to Buy at Peel Hunt

Close Brothers Group plc (LON:CBG) was upgraded by Peel Hunt to a “buy” rating in a note issued to investors on Thursday. The brokerage currently has a GBX 1,600 ($21.04) price target on the stock. Peel Hunt’s price target would indicate a potential upside of 14.70% from the company’s previous close. CBG has been the […]
LEG Immobilien AG (LEGIF) Lifted to Buy at Zacks Investment Research

LEG Immobilien AG (LEGIF) Lifted to Buy at Zacks Investment Research

LEG Immobilien AG (OTCMKTS:LEGIF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. The firm presently has a $117.00 price target on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 11.10% from the stock’s current price. According […]
Cempra, Inc. (MLNT) Stock Rating Upgraded by Zacks Investment Research

Cempra, Inc. (MLNT) Stock Rating Upgraded by Zacks Investment Research

Cempra, Inc. (NASDAQ:MLNT) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Thursday. According to Zacks, “Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, […]
Zacks Investment Research Lowers Mesoblast Limited (MESO) to Strong Sell

Zacks Investment Research Lowers Mesoblast Limited (MESO) to Strong Sell

Mesoblast Limited (NASDAQ:MESO) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research report issued on Thursday. According to Zacks, “Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as […]
Zacks Investment Research Lowers Materialise NV (MTLS) to Hold

Zacks Investment Research Lowers Materialise NV (MTLS) to Hold

Materialise NV (NASDAQ:MTLS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday. According to Zacks, “Materialise NV is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, […]
Zacks Investment Research Downgrades Motorcar Parts of America, Inc. (MPAA) to Sell

Zacks Investment Research Downgrades Motorcar Parts of America, Inc. (MPAA) to Sell

Motorcar Parts of America, Inc. (NASDAQ:MPAA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Thursday. According to Zacks, “Motorcar Parts of America, Inc. is a manufacturer, remanufacturer and distributor of automotive aftermarket parts, including alternators, starters, wheel hub assembly, brake master cylinders, brake […]
Mazor Robotics Ltd. (MZOR) Upgraded at Zacks Investment Research

Mazor Robotics Ltd. (MZOR) Upgraded at Zacks Investment Research

Mazor Robotics Ltd. (NASDAQ:MZOR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Thursday. According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), […]
FirstGroup plc (FGP) Upgraded to Sector Performer by Royal Bank Of Canada

FirstGroup plc (FGP) Upgraded to Sector Performer by Royal Bank Of Canada

FirstGroup plc (LON:FGP) was upgraded by Royal Bank Of Canada to a “sector performer” rating in a report released on Thursday, Marketbeat reports. The brokerage currently has a GBX 110 ($1.45) target price on the transport operator’s stock, down from their prior target price of GBX 115 ($1.51). Royal Bank Of Canada’s price objective would […]
Royal Bank Of Canada Lowers Talktalk Telecom Group PLC (TALK) to Sector Performer

Royal Bank Of Canada Lowers Talktalk Telecom Group PLC (TALK) to Sector Performer

Talktalk Telecom Group PLC (LON:TALK) was downgraded by equities researchers at Royal Bank Of Canada to a “sector performer” rating in a report released on Thursday, Marketbeat.com reports. They presently have a GBX 190 ($2.50) price target on the stock, down from their previous price target of GBX 225 ($2.96). Royal Bank Of Canada’s target […]
Plymouth Industrial REIT, Inc. (PLYM) Stock Rating Upgraded by Zacks Investment Research

Plymouth Industrial REIT, Inc. (PLYM) Stock Rating Upgraded by Zacks Investment Research

Plymouth Industrial REIT, Inc. (NYSEAMERICAN:PLYM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The brokerage currently has a $20.00 target price on the stock. Zacks Investment Research‘s price objective points to a potential upside of 8.70% from the company’s previous close. According to […]
Pearson, PLC (PSO) Upgraded to “Buy” by Zacks Investment Research

Pearson, PLC (PSO) Upgraded to “Buy” by Zacks Investment Research

Pearson, PLC (NYSE:PSO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Thursday. The firm currently has a $10.00 price target on the stock. Zacks Investment Research‘s price objective indicates a potential upside of 8.81% from the stock’s current price. According to Zacks, “Pearson […]
Sturm, Ruger & Company, Inc. (RGR) Upgraded by Zacks Investment Research to “Hold”

Sturm, Ruger & Company, Inc. (RGR) Upgraded by Zacks Investment Research to “Hold”

Sturm, Ruger & Company, Inc. (NYSE:RGR) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued on Thursday. According to Zacks, “Sturm, Ruger & Co., Inc. is one of the nation’s leading manufacturers of rugged, reliable firearms for the commercial sporting market. As a full-line […]
AVEVA Group plc (AVV) Lifted to “Overweight” at Barclays PLC

AVEVA Group plc (AVV) Lifted to “Overweight” at Barclays PLC

AVEVA Group plc (LON:AVV) was upgraded by equities research analysts at Barclays PLC to an “overweight” rating in a research report issued to clients and investors on Thursday. The firm presently has a GBX 3,200 ($42.09) price target on the stock, up from their prior price target of GBX 2,800 ($36.83). Barclays PLC’s price objective […]
Recro Pharma, Inc. (REPH) Rating Lowered to Hold at Zacks Investment Research

Recro Pharma, Inc. (REPH) Rating Lowered to Hold at Zacks Investment Research

Recro Pharma, Inc. (NASDAQ:REPH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. According to Zacks, “Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is […]
Zacks Investment Research Downgrades Redfin Corporation (RDFN) to Hold

Zacks Investment Research Downgrades Redfin Corporation (RDFN) to Hold

Redfin Corporation (NASDAQ:RDFN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. According to Zacks, “Redfin Corporation is engaged in providing residential real estate search and brokerage services. The Company provides an online real estate marketplace and provides real estate services, […]
Dipexium Pharmaceuticals, Inc. (PLXP) Cut to Sell at Zacks Investment Research

Dipexium Pharmaceuticals, Inc. (PLXP) Cut to Sell at Zacks Investment Research

Dipexium Pharmaceuticals, Inc. (NASDAQ:PLXP) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Thursday. According to Zacks, “PLx Pharma Inc. is a specialty pharmaceutical company. It focused on developing clinically validated and patent-protected PLxGuard(TM) delivery system to provide safe and effective aspirin products. PLx […]
Reata Pharmaceuticals, Inc. (RETA) Rating Lowered to Sell at Zacks Investment Research

Reata Pharmaceuticals, Inc. (RETA) Rating Lowered to Sell at Zacks Investment Research

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday. According to Zacks, “Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing and commercializing product candidates which modulate the activity of regulatory proteins […]
NetEase, Inc. (NTES) Downgraded by CLSA

NetEase, Inc. (NTES) Downgraded by CLSA

NetEase, Inc. (NASDAQ:NTES) was downgraded by research analysts at CLSA from an “underperform” rating to a “sell” rating in a research note issued on Thursday, Marketbeat Ratings reports. They currently have a $283.00 price objective on the technology company’s stock. CLSA’s target price would indicate a potential downside of 22.99% from the stock’s current price. […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.